{
  "openalex_id": "W4389227614",
  "doi": "https://doi.org/10.1158/1535-7163.targ-23-b048",
  "title": "Abstract B048: NUC-3373 in combination with irinotecan (NUFIRI) or oxaliplatin (NUFOX) and bevacizumab for second-line treatment of patients with advanced colorectal cancer (NuTide:302)",
  "abstract": "Abstract Background: Fluoropyrimidines, such as 5-FU, exert anti-cancer activity via fluorodeoxyuridine-monophosphate (FUDR-MP). NUC-3373, a phosphoramidate transformation of FUDR-MP, generates high intracellular levels of FUDR-MP; avoiding toxic metabolite generation; and improving pharmacokinetics to enable more convenient administration. NuTide:302 is a three-part study investigating NUC-3373 in combination with chemotherapy agents used for the treatment of metatstaic CRC (mCRC). Part 1 established the safety of NUC-3373 in combination with leucovorin (LV) . Part 2 investigated NUC-3373 + LV in dose-escalation cohorts with either irinotecan (NUFIRI) or oxaliplatin (NUFOX) and determined the MTDs. Parts 1 and 2 established that LV had no effect on the safety or PK profile of NUC-3373 and the addition of oxaliplatin and irinotecan was well-tolerated. Here we present data from Part 3 (ongoing) which investigates NUFIRI and NUFOX in combination with bevacizumab (NUFIRI-bev; NUFOX-bev). Methods: Patients (pts) who had received 1 prior fluropyrimindine-containing therapy for mCRC were treated with either NUFIRI-bev (1,500 mg/m2 NUC-3373 (Q1W); 400 mg/m2 LV (Q1W); 180 mg/m2 irinotecan (Q2W); 5 mg/kg bevacizumab (Q2W)) or NUFOX-bev (1,875 mg/m2 NUC-3373 (Q1W); 400 mg/m2 LV (Q1W); 85 mg/m2 oxaliplatin (Q2W); 5 mg/kg bevacizumab (Q2W)). Results: At the time of data cut-off, 14 pts had been treated (NUFIRI-bev n=8; NUFOX-bev n=6); median age 60 (range: 37-81), 36% female, 38% ECOG 0 and 36% with liver metastases. In the NUFIRI-bev arm, there were no Grade 3 TRAEs. Seven pts (88%) achieved prolonged SD (median= 5.5 mo; range= 3.7-7.4) and 5 pts are ongoing. In the NUFOX-bev arm, Grade 3 TRAEs (occurring in 2 pts) were pancreatitis, ALT increased and hypokalaemia. Four pts (67%) achieved prolonged SD (median= 5 mo; range= 3-6.5) and 5 pts are ongoing. Updated safety and efficacy data will be presented. Conclusions:This study demonstrated safety and anti-tumour activity of NUFIRI-bev and NUFOX-bev in previously treated mCRC patients . A randomised Phase 2 study is currently investigating the safety and efficacy of NUFIRI-bev vs FOLRIFI-bev in 171 second-line pts with CRC (NuTide:323). Clinical trial information: NCT03428958 Citation Format: Khurum Khan, Uma Mukherjee, Benjamin L Schlechter, Kristen K Ciombor, Aglaia Skolariki, Andrew L Coveler, Janet S Graham, Mary Linton Peters, Stacey A Cohen, Niharika Mettu, Hélène Marijon, David Cosgrove, Fiona G McKissock, Elisabeth Oelmann, Jeffrey D Bloss, Sarah P Blagden, Aimery de Gramont, Jordan Berlin, T.R. Jeffry Evans. NUC-3373 in combination with irinotecan (NUFIRI) or oxaliplatin (NUFOX) and bevacizumab for second-line treatment of patients with advanced colorectal cancer (NuTide:302) [abstract]. In: Proceedings of the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics; 2023 Oct 11-15; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2023;22(12 Suppl):Abstract nr B048.",
  "authors": [
    {
      "display_name": "Khurum Khan",
      "id": "A5103155707",
      "orcid": "https://orcid.org/0000-0003-1887-629X",
      "institutions": [
        {
          "id": "I1340918713",
          "display_name": "University College London Hospitals NHS Foundation Trust",
          "country_code": "GB",
          "type": "healthcare"
        },
        {
          "id": "I45129253",
          "display_name": "University College London",
          "country_code": "GB",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Khurum Khan"
    },
    {
      "display_name": "Uma Mukherjee",
      "id": "A5053524419",
      "orcid": "https://orcid.org/0000-0001-6693-8788",
      "institutions": [
        {
          "id": "I1340918713",
          "display_name": "University College London Hospitals NHS Foundation Trust",
          "country_code": "GB",
          "type": "healthcare"
        },
        {
          "id": "I45129253",
          "display_name": "University College London",
          "country_code": "GB",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Uma Mukherjee"
    },
    {
      "display_name": "Benjamin L. Schlechter",
      "id": "A5062338114",
      "orcid": "https://orcid.org/0000-0002-1529-3278",
      "institutions": [
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Benjamin L Schlechter"
    },
    {
      "display_name": "Kristen K. Ciombor",
      "id": "A5047170855",
      "orcid": "https://orcid.org/0000-0002-8992-9515",
      "institutions": [
        {
          "id": "I901861585",
          "display_name": "Vanderbilt University Medical Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Kristen K Ciombor"
    },
    {
      "display_name": "Aglaia Skolariki",
      "id": "A5003300741",
      "orcid": "https://orcid.org/0000-0001-5354-0359",
      "institutions": [
        {
          "id": "I2801179840",
          "display_name": "Churchill Hospital",
          "country_code": "GB",
          "type": "healthcare"
        },
        {
          "id": "I40120149",
          "display_name": "University of Oxford",
          "country_code": "GB",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Aglaia Skolariki"
    },
    {
      "display_name": "Andrew L. Coveler",
      "id": "A5060994391",
      "orcid": "https://orcid.org/0000-0003-1710-5637",
      "institutions": [
        {
          "id": "I4210089486",
          "display_name": "Fred Hutch Cancer Center",
          "country_code": "US",
          "type": "nonprofit"
        },
        {
          "id": "I201448701",
          "display_name": "University of Washington",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Andrew L Coveler"
    },
    {
      "display_name": "Janet Graham",
      "id": "A5072099525",
      "orcid": "https://orcid.org/0000-0002-2048-2698",
      "institutions": [
        {
          "id": "I2800373718",
          "display_name": "Beatson West of Scotland Cancer Centre",
          "country_code": "GB",
          "type": "healthcare"
        },
        {
          "id": "I7882870",
          "display_name": "University of Glasgow",
          "country_code": "GB",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Janet S Graham"
    },
    {
      "display_name": "Mary Linton B. Peters",
      "id": "A5020352485",
      "orcid": "https://orcid.org/0000-0003-0905-7583",
      "institutions": [
        {
          "id": "I1316535847",
          "display_name": "Beth Israel Deaconess Medical Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Mary Linton Peters"
    },
    {
      "display_name": "Stacey A. Cohen",
      "id": "A5062531028",
      "orcid": "https://orcid.org/0000-0002-6207-9856",
      "institutions": [
        {
          "id": "I4210089486",
          "display_name": "Fred Hutch Cancer Center",
          "country_code": "US",
          "type": "nonprofit"
        },
        {
          "id": "I201448701",
          "display_name": "University of Washington",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Stacey A Cohen"
    },
    {
      "display_name": "Niharika B. Mettu",
      "id": "A5072094247",
      "orcid": "https://orcid.org/0000-0002-7821-3298",
      "institutions": [
        {
          "id": "I4210126298",
          "display_name": "Duke Medical Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Niharika Mettu"
    },
    {
      "display_name": "Hélène Marijon",
      "id": "A5038516928",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210136760",
          "display_name": "Institut Hospitalier Franco Britannique",
          "country_code": "FR",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Hélène Marijon"
    },
    {
      "display_name": "David Cosgrove",
      "id": "A5037784680",
      "orcid": "https://orcid.org/0000-0003-2700-5656",
      "institutions": [
        {
          "id": "I4210095874",
          "display_name": "Compass Oncology",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "David Cosgrove"
    },
    {
      "display_name": "Fiona G. McKissock",
      "id": "A5050715485",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210125074",
          "display_name": "Nucana (United Kingdom)",
          "country_code": "GB",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Fiona G McKissock"
    },
    {
      "display_name": "Elisabeth Oelmann",
      "id": "A5030548564",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210125074",
          "display_name": "Nucana (United Kingdom)",
          "country_code": "GB",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Elisabeth Oelmann"
    },
    {
      "display_name": "Jeffrey D. Bloss",
      "id": "A5110479247",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210125074",
          "display_name": "Nucana (United Kingdom)",
          "country_code": "GB",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Jeffrey D Bloss"
    },
    {
      "display_name": "Sarah P. Blagden",
      "id": "A5068550336",
      "orcid": "https://orcid.org/0000-0001-8783-3491",
      "institutions": [
        {
          "id": "I2801179840",
          "display_name": "Churchill Hospital",
          "country_code": "GB",
          "type": "healthcare"
        },
        {
          "id": "I40120149",
          "display_name": "University of Oxford",
          "country_code": "GB",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Sarah P Blagden"
    },
    {
      "display_name": "Aimery de Gramont",
      "id": "A5054670872",
      "orcid": "https://orcid.org/0000-0001-7940-9877",
      "institutions": [
        {
          "id": "I4210136760",
          "display_name": "Institut Hospitalier Franco Britannique",
          "country_code": "FR",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Aimery de Gramont"
    },
    {
      "display_name": "Jordan Berlin",
      "id": "A5039492614",
      "orcid": "https://orcid.org/0000-0001-7571-2385",
      "institutions": [
        {
          "id": "I901861585",
          "display_name": "Vanderbilt University Medical Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Jordan Berlin"
    },
    {
      "display_name": "T.R. Jeffry Evans",
      "id": "A5038656790",
      "orcid": "https://orcid.org/0000-0002-4175-914X",
      "institutions": [
        {
          "id": "I2800373718",
          "display_name": "Beatson West of Scotland Cancer Centre",
          "country_code": "GB",
          "type": "healthcare"
        },
        {
          "id": "I7882870",
          "display_name": "University of Glasgow",
          "country_code": "GB",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "T.R. Jeffry Evans"
    }
  ],
  "publication_year": 2023,
  "publication_date": "2023-12-01",
  "type": "article",
  "cited_by_count": 1,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S48437117",
    "display_name": "Molecular Cancer Therapeutics",
    "issn_l": "1535-7163",
    "issn": [
      "1535-7163",
      "1538-8514"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310320273"
  },
  "volume": "22",
  "issue": "12_Supplement",
  "first_page": "B048",
  "last_page": "B048",
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C2780259306",
      "display_name": "Irinotecan",
      "level": 4,
      "score": 0.8999232
    },
    {
      "id": "C2777802072",
      "display_name": "Bevacizumab",
      "level": 3,
      "score": 0.7926488
    },
    {
      "id": "C2780962732",
      "display_name": "Oxaliplatin",
      "level": 4,
      "score": 0.671887
    },
    {
      "id": "C526805850",
      "display_name": "Colorectal cancer",
      "level": 3,
      "score": 0.56861585
    },
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.4940377
    },
    {
      "id": "C98274493",
      "display_name": "Pharmacology",
      "level": 1,
      "score": 0.45319852
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.45088753
    },
    {
      "id": "C112705442",
      "display_name": "Pharmacokinetics",
      "level": 2,
      "score": 0.4230134
    },
    {
      "id": "C121608353",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.355999
    },
    {
      "id": "C2776694085",
      "display_name": "Chemotherapy",
      "level": 2,
      "score": 0.3057524
    }
  ],
  "topics": [
    {
      "id": "T11067",
      "display_name": "Colorectal Cancer Treatments and Studies",
      "score": 0.9879
    },
    {
      "id": "T10417",
      "display_name": "Lung Cancer Treatments and Mutations",
      "score": 0.9741
    },
    {
      "id": "T11752",
      "display_name": "Cancer Treatment and Pharmacology",
      "score": 0.9654
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.1158/1535-7163.targ-23-b048",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T14:56:46.681440",
  "source_database": "OpenAlex"
}